Kymera Therapeutics, Inc. ($KYMR)
Filing Information
| Accession Number | 0001193125-26-091985 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 4, 2026 |
| Document | View SEC Filing |
Transactions
9
Total Shares
43,683
Total Value
$515,594.13
P&L
+inf% (+$2,939,154.75)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | Common Stock | โ | Mar 2, 2026 | Grant/Award | 12,575 | $0.00 | $0.00 | 79,768 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Mar 2, 2026 | Sale | 549 | $87.75 | $48,175.24 | 79,219 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Mar 2, 2026 | Sale | 383 | $88.50 | $33,895.65 | 78,836 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Mar 2, 2026 | Sale | 1,107 | $89.66 | $99,250.74 | 77,729 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Mar 4, 2026 | Sale | 394 | $84.00 | $33,094.62 | 77,335 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Mar 4, 2026 | Sale | 2,017 | $85.04 | $171,518.42 | 75,318 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Mar 4, 2026 | Sale | 1,150 | $85.78 | $98,647.80 | 74,168 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Mar 4, 2026 | Sale | 358 | $86.62 | $31,011.64 | 73,810 | Direct | โ | View Details | |
Chief Operating Officer | Stock Option (Right to Buy) | Derivative | Mar 2, 2026 | Grant/Award | 25,150 | $0.00 | $0.00 | 25,150 | Direct | โ | View Details |